Last Updated: September 28, 2026

Ascent Pharms Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ASCENT PHARMS INC

ASCENT PHARMS INC has fifty-two approved drugs.

Summary for Ascent Pharms Inc

US Patents:	0
Tradenames:	39
Ingredients:	39
NDAs:	52

Drugs and US Patents for Ascent Pharms Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ascent Pharms Inc	BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE	buprenorphine hydrochloride; naloxone hydrochloride	TABLET;SUBLINGUAL	219727-001	Dec 15, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ascent Pharms Inc	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	213709-001	Apr 22, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ascent Pharms Inc	METHADONE HYDROCHLORIDE	methadone hydrochloride	TABLET;ORAL	211228-001	Jan 3, 2019	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ascent Pharms Inc	GABAPENTIN	gabapentin	CAPSULE;ORAL	214956-002	May 10, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ascent Pharms Inc	LEVOTHYROXINE SODIUM	levothyroxine sodium	TABLET;ORAL	215259-003	Jan 18, 2023	AB4	RX	No	No		⤷ Start Trial				⤷ Start Trial
Ascent Pharms Inc	LISDEXAMFETAMINE DIMESYLATE	lisdexamfetamine dimesylate	CAPSULE;ORAL	217442-001	Aug 25, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ASCENT PHARMS INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.